Journal of
Neuroscience and Behavioral Health

  • Abbreviation: J. Neurosci. Behav. Health
  • Language: English
  • ISSN: 2141-2286
  • DOI: 10.5897/JNBH
  • Start Year: 2009
  • Published Articles: 66

Full Length Research Paper

Medication-related factors of non adherence among patients with schizophrenia and bipolar disorder: Outcome of a cross-sectional survey in Maiduguri, North-eastern Nigeria

Ibrahim, A.W.1*, Pindar, S.K.1, Yerima, M.M.1, Rabbebe, I.B.2, Shehu, S.3, Garkuwa, H.A.4, Bashir, I.Y.5, Wakil, M.A.1 and Yahya, S.J.6
1Mental Health Department, College of Medical Sciences, University of Maiduguri, Borno State, Nigeria. 2Clinical Services Department, Federal Neuropsychiatric Hospital, Maiduguri, Borno State, Nigeria. 3Department of Psychiatry, Bayero University Kano, Kano State, Nigeria. 4Clinical Services Department, Abubakar Tafawa Balewa, University Teaching Hospital, Bauchi State, Nigeria. 5Clinical Services Department, Federal Teaching Hospital, Gombe, Gombe State, Nigeria. 6Community Medicine Department, College of Medical Sciences, University of Maiduguri, Borno State, Nigeria.
Email: [email protected]

  •  Received: 19 May 2015
  •  Accepted: 02 June 2015
  •  Published: 30 June 2015

References

Adam J, Scott J (2000). Predicting medication adherence in severe mental disorders. Acta. Psychiatr. Scand. 101:119-124.
crossref
 
Adeponle AB, Thombs BD, Adelekan ML, Kirmayer LJ (2009). Family participation in treatment, post discharge appointment and medication adherence at a Nigerian psychiatric hospital. Br. J. Psychiatry 194:86-87.
crossref
 
Adewuya AO, Owoeye OA, Erinfolami AR, Coker AO, Ogun OC, Okewole AO, Dada MU, Eze CN, Bello-Mojeed MA, Akindipe TO, Olagunju AT, Etim E. (2009). Prevalence and correlates of poor medication adherence amongst psychiatric patients in South-western Nigeria. Gen. Hosp. Psychiatry 31(2):167-174.
crossref
 
Aloba O, Fatoye O, Mapayi B, Akinsulore S (2013). A review of quality of life studies among Nigerian patients with psychiatric disorders. Afr. J. Psychiatry 16:333-337.
 
American Pharmacists Association (2013). Improving medication adherence in patients with severe mental illness. Pharmacy Today 19(6):69-80.
 
Amr M, El-Mogy A, El-Masry R (2013). Adherence in Egyptian patients with schizophrenia: the role of insight, medication beliefs and spirituality. Arab J. Psychiatry 24(1):60-68.
 
Baldessarini R, Henk H, Sklar A, Chang J, Leahy L (2008). Psychotropic medications for patients with bipolar disorder in the United States: Polytherapy and Adherence. Psychiatr. Serv. 59(10):1175-1183.
crossref
 
Baldessarini RJ, Perry R, Pike J (2008). Factors associated with treatment nonadherence among US bipolar disorder patients. Hum. Psychopharmacol. 23(2):95-105.
crossref
 
Banerjee S, Varma RP (2013). Factors affecting non-adherence among patients diagnosed with unipolar depression in a psychiatric department of a tertiary hospital in Kolkata, India. Depress. Res. Treat. 1-12.
crossref
 
Barnes TR, Schizophrenia Consensus Group of the British Association of Psychopharmacology (2011). Evidence-based guidelines for the pharmacological treatment of schizophrenia: Recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 25(5):567-620.
crossref
 
Caldeira D, Vaz-carneiro A, Costa J (2014). The impact of dosing frequency on medication adherence in chronic cardiovascular disease: Systematic review and meta-analysis. Rev. Port. Cardiol. 33(7-8):431-437.
crossref
 
Chesney MA (2000). Factors affecting adherence to antiretroviral therapy. Clin. Infect. Dis. 30(2):171-6.
crossref
 
Danladi J, Kakjing D. Falang, Raymond A. Barde, Nanlok S. Jimam, Dauda A. Dangiwa, Hafsat O. Jimoh (2013). Pharmaceutical care and medication adherence in management of psychosis in a Nigerian tertiary hospital. J. Res. Pharm. Pract. 2(2):83-87.
crossref
 
Demoz Z, Legesse B, Teklay G, Demeke B, Eyob T, Shewamene Z, Abera M (2014). Medication adherence and its determinants among psychiatric patients in an Ethiopian referral hospital. Patient Prefer. Adherence 8:1329-1335.
Pubmed
 
DiBonaventura M, Gabriel S, Dupclay L, Gupta S, Kim E (2012). A patient perspective of the impact of medication side effects to adherence: results of a cross-sectional nationwide survey of patients with schizophrenia. BMC Psychiatry 12:20.
crossref
 
Dilla T, Ciudad A, Alvarez M (2013). Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Patient Prefer. Adherence 7:275-284.
crossref
 
Eticha T, Teklu A, Ali D, Solomon G (2015). Factors associated medication adherence among patients with schizophrenia in Mekelle. PLoS ONE 10(3):e0120560.
crossref
 
George D, Mallery P (2003). SPSS for windows step by step: a simple guide and reference. 11.0 update (4th edn) Boston: Allyn and Bacon.
 
Goodwin GM, Consensus group of the British Association of Psychopharmacology (2009). Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 23(4):346-388.
 
Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A (1987). The Vermont Longitudinal study of persons with severe mental illness, I: Methodology, Study sample, and Overall Status 32 years later. Am. J. Psychiatry 144(6):718-726.
crossref
 
Hauber AB, Han S, Yang JC, Gantz I, Tunceli K, Gonzalez JM, Brodovicz K, Alexander CM, Davies M, Iglay K, Zhang Q, Radican L (2013). Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer. Adherence 7:937 - 949.
crossref
 
Higashi K, Medic G, Littlewood KJ, Diez T, Granstrom O, De Hert M (2013). Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther. Adv. Psychopharmacol. 3(4):200-218.
crossref
 
Kane JM, Kishimoto T, Correll CU (2013). Non-adherence to medications in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry 12:216-226.
crossref
 
Kassis IT, Ghuloum S, Mousa H, Bener A (2014). Treatment non-compliance of psychiatric patients; are patients satisfied from their psychiatrist? Br. J. Med. Med. Res. 4(2):785 - 796.
 
Keck PE Jr, McElroy SL, Strakowski SM, Stanton SP, Kizer DL, Balistreri TM, Bennett JA, Tugrul KC, West SA. (1996). Factors associated with pharmacologic noncompliance in patients with mania. J. Clin. Psychiatry 57:292-297.
Pubmed
 
Kretchy IA, Owusu-Daaku FT, Danquah SA (2014). Mental health in hypertension: assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int. J. Ment. Health Syst. 8(25):1-6.
crossref
 
Lacro JP, Dunn LB, Dolder CR, Leckband SG, Veste DV (2002). Prevalence of and risk factors for medication nonadherence in Patients with Schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry 63(10): 892-909.
crossref
 
Latalova K, Prasko J, Diveky T, Kamaradova D, Verlatova H (2011). Quality of life in patients with bipolar disorder - A comparison with schizophrenic and healthy controls. Psychiatr. Danub. 23(1):21-26.
Pubmed
 
Morisky DE, Ang A, Krousel-Wood M, Ward H (2008). Predictive validity of a Medication adherence measure for hypertension control. J. Clin. Hypertens.10(5):348-354.
crossref
 
National Bureau of Statistics (NBS) (2013). Revised poverty statistics. NBS, Abuja.
 
Okpataku CI, Kwanashie HO, Ejiofor JI, Olisah VO (2015). Medication compliance behavior in psychiatric out-patients with psychoactive substance use comorbidity in a Nigerian tertiary hospital. Niger. J. Clin. Pract. 18(3):371-376.
crossref
 
Pfeiffer PN, Ganoczy D, Valenstein M (2008). Dosing frequency and medication adherence to antipsychotic medications. Psychiatr. Serv. 59(10):1207-1210.
crossref
 
Razzouk D, Kayo M, Sousa A, Gregorio G, Cogo-Moreira H, Cardoso AA, Mari Jde J. (2015). The impact of antipsychotic polytherapy in the public health care in Sao-Paolo, Brazil. PLoS ONE 10(4):e0124791.
crossref
 
Rietschel M, Georgi A, Schmael C, Schirmbeck F, Strohmaier J, Boesshenz KV, Schwarz M, Nöthen MM, Schulze TG. (2009). Premorbid adjustment: a phenotype highlighting a distinction rather than an overlap between schizophrenia and bipolar disorder. Schizophr. Res. 110:33-39.
crossref
 
Saarni SI, Viertio S, Perala J, Koskinen S, Lonnqvist J, Suvisaari J (2010). Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br. J. Psychiatry 197:386-394.
crossref
 
Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV (2006). Treatment adherence with antipsychotic medications in bipolardisorder. Bipolar. Disord. 8(3):232-241.
crossref
 
Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV (2007). Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr. Serv. 58(6):855-863.
crossref
 
United Nations Development Group (2003). Indicators for monitoring the millennium development goals: definitions, rationale, concepts and sources. United Nations. October 2003; New York NY, 10017.
 
United Nations Development Programme (2013). Nigerian Millennium Development Goals Report. 2013. Available at: www.mdgs.gov.ng on van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J (2007). Patient adherence to treatment: a review of reviews. BMC Health Serv. Res. 7(55): 1 - 13.
 
Weiden PL, Miller AL (2001). Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications. J. Psychiatr. Pract. 7(1):4 -47.
crossref
 
Yang J, Ko YH, Paik JW, Lee MS, Han C, Joe SH, Jung IK, Jung HG, Kim SH. (2012). Symptom severity and attitudes towards medication: impacts on adherence in outpatients with schizophrenia. Schizophr. Res. 134(2-3):226-31.
crossref